A. John Barrett

8.5k total citations · 1 hit paper
109 papers, 6.0k citations indexed

About

A. John Barrett is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, A. John Barrett has authored 109 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Hematology, 48 papers in Immunology and 23 papers in Oncology. Recurrent topics in A. John Barrett's work include Hematopoietic Stem Cell Transplantation (54 papers), Immune Cell Function and Interaction (31 papers) and T-cell and B-cell Immunology (28 papers). A. John Barrett is often cited by papers focused on Hematopoietic Stem Cell Transplantation (54 papers), Immune Cell Function and Interaction (31 papers) and T-cell and B-cell Immunology (28 papers). A. John Barrett collaborates with scholars based in United States, United Kingdom and Malaysia. A. John Barrett's co-authors include Nancy F. Hensel, Neal S. Young, Susan F. Leitman, Richard Childs, Bipin N. Savani, Erkut Bahceci, Cynthia E. Dunbar, Minoo Battiwalla, Emmanuel Clave and Nathalie Contentin and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.

In The Last Decade

A. John Barrett

107 papers receiving 5.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation

2000 770 citations Richard Childs, Susan F. Leitman et al. profile →

Peers

Countries citing papers authored by A. John Barrett

Since Specialization

Citations

This map shows the geographic impact of A. John Barrett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. John Barrett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. John Barrett more than expected).

Fields of papers citing papers by A. John Barrett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. John Barrett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. John Barrett. The network helps show where A. John Barrett may publish in the future.

Co-authorship network of co-authors of A. John Barrett

This figure shows the co-authorship network connecting the top 25 collaborators of A. John Barrett. A scholar is included among the top collaborators of A. John Barrett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. John Barrett. A. John Barrett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Framingham Risk Score Is an Ineffective Screening Strategy for Coronary Heart Disease in Long-Term Allogeneic Hematopoietic Cell Transplant Survivors 2020 ·SHILAP Revista de lepidopterología ·(unknown), Marcus Y. Chen, Sujata M. Shanbhag, (unknown), Xin Tian, Sawa Ito, Priyanka A. Pophali, (unknown), Robert Q. Le, (unknown), (unknown), Richard Childs, A. John Barrett, Minoo Battiwalla	4
2	Effect of Normothermic Machine Perfusion on Outcomes after Steatotic Liver Transplantation: A First Assessment 2017 ·Transplantation ·(unknown), David Nasralla, (unknown), Hynek Mergental, Annemarie Weißenbacher, A. John Barrett, (unknown), Rutger J. Ploeg, Leanne Hodson, Peter J. Friend	1
3	A HISTOLOGICAL AND BIOCHEMICAL ASSESSMENT OF STEATOTIC LIVERS UNDERGOING NORMOTHERMIC MACHINE PERFUSION 2017 ·Transplant International ·Carlo Ceresa, David Nasralla, (unknown), Hynek Mergental, Wayel Jassem, (unknown), Charles Imber, A. John Barrett, A. Clay Clark, Constantin Coussios, Richard Ploeg, Leanne Hodson, P Friend	1
4	Ex vivo T-cell–depleted allogeneic stem cell transplantation for hematologic malignancies: The search for an optimum transplant T-cell dose and T-cell add-back strategy 2017 ·Cytotherapy ·(unknown), Xin Tian, Sawa Ito, Pawel Muranski, (unknown), (unknown), (unknown), Nancy F. Hensel, David F. Stroncek, Minoo Battiwalla, A. John Barrett	5
5	CD34+ selection and the severity of oropharyngeal mucositis in total body irradiation-based allogeneic stem cell transplantation 2015 ·Supportive Care in Cancer ·(unknown), (unknown), (unknown), (unknown), Neil Dunavin, Christopher S. Hourigan, Robert Q. Le, (unknown), Sawa Ito, David F. Stroncek, Marianna Sabatino, A. John Barrett, Minoo Battiwalla	5
6	Identification of novel microRNA signatures linked to acquired aplastic anemia 2015 ·Haematologica ·Kohei Hosokawa, Pawel Muranski, Xingmin Feng, Keyvan Keyvanfar, Danielle M. Townsley, Bogdan Dumitriu, (unknown), Sachiko Kajigaya, James G. Taylor, Christopher S. Hourigan, A. John Barrett, Neal S. Young	35
7	The clinical and financial burden of pre-emptive management of cytomegalovirus disease after allogeneic stem cell transplantation—implications for preventative treatment approaches 2014 ·Cytotherapy ·(unknown), (unknown), Sawa Ito, Pawel Muranski, Christopher S. Hourigan, (unknown), (unknown), (unknown), (unknown), Lisa Cook, Richard Childs, Minoo Battiwalla, A. John Barrett	54
8	CMV reactivation is associated with a lower incidence of relapse after allo-SCT for CML 2013 ·Bone Marrow Transplantation ·Sawa Ito, Priyanka A. Pophali, (unknown), (unknown), (unknown), Gary A. Fahle, Richard Childs, Minoo Battiwalla, A. John Barrett	79
9	Donor lymphocyte count and thymic activity predict lymphocyte recovery and outcomes after matched-sibling hematopoietic stem cell transplant 2012 ·Haematologica ·(unknown), J. Joseph Melenhorst, Colin O. Wu, (unknown), Sawa Ito, Ilseung Cho, Nancy F. Hensel, Minoo Battiwalla, A. John Barrett	18
10	Does chemotherapy modify the immune surveillance of hematological malignancies? 2008 ·Leukemia ·A. John Barrett, Bipin N. Savani	36
11	T Cell Therapy in Allogeneic Stem Cell Transplantation 2007 ·Biology of Blood and Marrow Transplantation ·J.H. Frederik Falkenburg, Helen E. Heslop, A. John Barrett	13
12	Overcoming graft rejection in heavily transfused and allo‐immunised patients with bone marrow failure syndromes using fludarabine‐based haematopoietic cell transplantation 2006 ·British Journal of Haematology ·Ramaprasad Srinivasan, Yoshiyuki Takahashi, J. Philip McCoy, Igor Espinoza‐Delgado, (unknown), Takehito Igarashi, Andreas Lundqvist, A. John Barrett, Neal S. Young, Nancy L. Geller, Richard Childs	83
13	Cytogenetic abnormalities in paroxysmal nocturnal haemoglobinuria usually occur in haematopoietic cells that are glycosylphosphatidylinositol‐anchored protein (GPI‐AP) positive 2003 ·British Journal of Haematology ·Elaine M. Sloand, Monika Führer, Keyvan Keyvanfar, Lori Mainwaring, Jaroslaw P. Maciejewski, Yu Wang, Sarah Johnson, A. John Barrett, Neal S. Young	13
14	Optimized clinical-scale culture conditions for ex vivoselective depletion of host-reactive donor lymphocytes: astrategy for GVHD prophylaxis in allogeneic peripheral bloodstem cell transplantation 2002 ·Cytotherapy ·Scott R. Solomon, (unknown), Charles S. Carter, (unknown), (unknown), John Schindler, (unknown), (unknown), Jaroslav Michálek, (unknown), (unknown), Ellen S. Vitetta, A. John Barrett	1
15	Massive immune haemolysis after allogeneic peripheral blood stem cell transplantation with minor ABO incompatibility 2001 ·British Journal of Haematology ·Charles D. Bolan, Richard Childs, Jo L. Procter, A. John Barrett, Susan F. Leitman	72
16	Effect of nucleated marrow cell dose on relapse and survival in identical twin bone marrow transplants for leukemia. 2000 ·Blood ·A. John Barrett, Olle Ringdén, Mei‐Jie Zhang, Asad Bashey, Jean‐Yves Cahn, Mitchell S. Cairo, Robert Peter Gale, Aloïs Gratwohl, Franco Locatelli, Rodrigo Martino, Kirk R. Schultz, Pierre Tiberghien	66
17	WR-1065, the active metabolite of amifostine (ethyol®), does not inhibit the cytotoxic effects of a broad range of standard anticancer drugs against human ovarian and breast cancer cells 1996 ·European Journal of Cancer ·David S. Alberts, L A Speicher, Mary F. Krutzsch, Julie Wymer, Robert L. Capizzi, (unknown), A. John Barrett, Mikel Aickin	24
18	Interaction of natural killer cells with MHC class II: reversal of HLA‐DR1‐mediated protection of K562 transfectant from natural killer cell‐mediated cytolysis by brefeldin‐A 1996 ·Immunology ·Yawei Jiang, Daniel Couriel, Dimitriοs Mavroudis, Philippe Lewalle, Vera Malkovska, Nancy F. Hensel, Said Dermime, Jeffrey J. Molldrem, A. John Barrett	25
19	Bone marrow transplantation for adults and children with poor risk acute lymphoblastic leukaemia in first complete remission. 1988 ·PubMed ·D. McCarthy, A. John Barrett, D. Macdonald, (unknown), C Poynton, (unknown), K. Hugh‐Jones, Bob Phillips	14
20	Tetanus after allogeneic bone-marrow transplantation. 1982 ·BMJ ·J.R. Kendra, Ozay Halil, A. John Barrett, Sydney Selwyn	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact